Saturday, September 21, 2019
    Latest

    Anti-CD19

    Home Anti-CD19
    China Oncology
    Anti-CD19

    Chinese Research Reveals Sequential Infusion of Humanized CD19-Modified & CD22-modified  CAR-T...

    0
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    159 West Broadway Suite 200
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved